Antibiotic resistance genes across a wide variety of metagenomes by Fitzpatrick, David A. & Walsh, Fiona
FEMS Microbiology Ecology, 92, 2016, fiv168
doi: 10.1093/femsec/fiv168
Advance Access Publication Date: 6 January 2016
Research Article
RESEARCH ARTICLE
Antibiotic resistance genes across a wide variety
of metagenomes
David Fitzpatrick† and Fiona Walsh∗†
Department of Biology, Maynooth University, Maynooth, Co. Kildare, W23 F2H6, Ireland
∗Corresponding author: Department of Biology, Maynooth University, Maynooth, Co. Kildare, W23 F2H6, Ireland. Tel: +353-14747246;
E-mail: Fiona.walsh@nuim.ie
†Both contributed equally to this work.
One sentence summary: Distribution and relative abundances of antibiotic resistance genes across the world from the ocean to the human gut and
everywhere in between.
Editor: Kornelia Smalla
Fiona Walsh, http://orcid.org/0000-0003-0789-1689
ABSTRACT
The distribution of potential clinically relevant antibiotic resistance (AR) genes across soil, water, animal, plant and human
microbiomes is not well understood. We aimed to investigate if there were differences in the distribution and relative
abundances of resistance genes across a variety of ecological niches. All sequence reads (human, animal, water, soil, plant
and insect metagenomes) from the MG-RAST database were downloaded and assembled into a local sequence database. We
show that there are many reservoirs of the basic form of resistance genes e.g. blaTEM, but the human and mammalian gut
microbiomes contain the widest diversity of clinically relevant resistance genes using metagenomic analysis. The human
microbiomes contained a high relative abundance of resistance genes, while the relative abundances varied greatly in the
marine and soil metagenomes, when datasets with greater than onemillion geneswere compared.While these results reflect
a bias in the distribution of AR genes across the metagenomes, we note this interpretation with caution. Metagenomics
analysis includes limits in terms of detection and identification of AR genes in complex and diverse microbiome
population. Therefore, if we do not detect the AR gene is it in fact not there or just below the limits of our techniques?
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INTRODUCTION
Antibiotic resistance (AR) genes are widespread and have been
identified in almost every microbiome throughout the planet
fromAntarctic ice to the phyllosphere, soil, insects, animals and
humans (Feller, Sonnet and Gerday 1995; de Kraker and van de
Sande-Bruinsma 2007; Allen et al. 2009; Cantas et al. 2013; Walsh
and Duffy 2013; Duffy, Holliger and Walsh 2014; Garcia-Migura
et al. 2014). Through the identification of AR genes, or putative
resistance genes, many scientific studies have come to the fol-
lowing conclusions:
(i) Soil is a major reservoir of AR genes (Finley et al. 2013;
Martı´nez 2008; Forsberg et al. 2014; Nesme et al. 2014; Su et al.
2014b).
(ii) Animals, especially food animals, are sources of AR genes
due to antibiotic use in agriculture (Wang et al. 2012; Ander-
sson and Hughes 2014).
(iii) The spreading of animal manure on land increases the abu-
ndance and diversity of transferable resistance genes pre-
sent (Heuer, Schmitt and Smalla 2011; Jechalke et al. 2013).
(iv) Fecal pollution of water causes AR gene pollution of fresh-
water and marine biomes (Alves et al. 2014; Jia et al. 2014).
(v) Antibiotic use in clinical settings has created selective
environments for the proliferation of antibiotic-resistant
pathogens (Bacquero et al. 1998).
Advances in next-generation sequencing have led to an ex-
plosion of data from a wide variety of microbiomes. These
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advances have also enabled research in the non-human and
non-animal microbiomes to extend beyond the culturable bac-
teria. Thus, enabling microbiologists to investigate the roles of
soil, water and plant microbiomes as reservoirs of AR genes.
However, the data analysed must be placed in the relevant con-
text. While no environment is completely free from AR genes,
it is vital to differentiate between the clinically relevant resis-
tance genes, in particular transferable resistance genes and re-
sistance genes, which are intrinsic to specific bacterial species.
This will then aid in the identification of the ecological roles of
clinically relevant AR genes, how they have been selected in dif-
ferent biomes and the risks they pose to the treatment of infec-
tions. In order to minimize the risks to human health posed by
AR genes in the environment and the risk to the environment by
waste containing AR genes, we must identify the critical points
of control, which are the AR gene hotspots (Berendonk et al.
2015). Our study utilized the freely available metagenome data
to investigate the ubiquitous resistance genes, and those, which
are microbiome specific in order to identify potential hotspots
of resistance.
MATERIALS AND METHODS
Metagenomics sequence data
Environmental shotgun sequencingmetagenomic datasetswere
downloaded from the MG-RAST metagenomic analysis server
(http://metagenomics.anl.gov/) (Meyer et al. 2008). Sequence
reads were annotated locally and combined into a local se-
quence database. Redundant sequences were removed from
appropriate datasets. Overall, our database contains data
from 10 181 metagenomic surveys encompassed within 432
metagenome datasets (Dataset 1, Supporting Information). The
total size of the database is approximately 3160 Gbp.
BLAST searches for AR genes
A local file of AR genes was created by downloading all se-
quence data from theAntibiotic ResistanceDatabase (ARDB) (Liu
and Pop 2009). The current version of ARDB contains 23 137 se-
quences classified into 380 AR gene types encoding resistance
to 249 antibiotics (Liu and Pop 2009). To avoid redundancy, a sin-
gle representative AR gene was selected for each AR gene type,
in addition the blaNDM gene sequence was included as this was
absent from the ARDB (Dataset 2, Supporting Information). All
381 AR genes were treated as query sequences and compared
to our local metagenomic database using BLASTp with a cut-
off expectation (E) value of <10−10 (Altschul et al. 1997). A read
was annotated as a potential AR gene if its top high-scoring seg-
ment pair (HSP) had a percent identity >90% and the HSP length
was greater than 60% of the query AR gene. The total number of
reads that pass these criteria for each AR gene was recorded and
labeled as AR reads. The relative abundance for each AR gene in
themetagenomewas calculated by dividing the specific number
of AR reads by the total number of reads in that metagenome.
RESULTS
Overall, our database contains data from 10 181 metagenomic
surveys encompassed within 432 metagenome datasets from
a wide variety of human, animal, plant and environmental
sources (Dataset 1, Supporting Information). Themetadata asso-
ciated with some of the MG-RAST datasets are poorly described
e.g. describing both the plant and rhizosphere in one project.
Therefore, we have described the overall patterns regarding the
biomes rather than compare within the biomes. In order to min-
imize stringency and expression bias, a read was annotated as
an AR gene if its top HSP had a percent identity >90% and the
HSP length was greater than 60% of the query AR gene.
Efflux resistance genes are present in commensal and
pathogenic bacteria as well as phytobacteria and environmen-
tal bacteria and contribute to the resistance armory of clinical
pathogens and defence mechanisms of non-pathogenic bacte-
ria. However, it is the upregulation of expression of the efflux
pumps, most frequently associated with a mutation in a repres-
sor gene that results in the resistance phenotype, rather than
the presence of the gene. The wild-type version of these genes
should not confer resistance following transfer to susceptible
bacteria (Martı´nez, Coque and Baquero 2015). Therefore, they
should not be considered a real risk when identified in metage-
nomic datasets (Martı´nez, Coque and Baquero 2015). Therefore,
we analysed the data in terms of non-efflux-mediated resistance
to identify AR genes, which have the greatest probabilities of
transferring to pathogenic bacteria. While some genes encod-
ing an AR efflux pump e.g. tetA, have been detected on mobile
elements, the vast majority of genes encoding efflux pumps are
not transferable. Other intrinsic resistance genes e.g. chromoso-
mally encoded beta-lactamases remain in the dataset as these
have been shown to transfer from the chromosome tomobile el-
ements. When these mobile elements are present in pathogenic
bacteria, they confer a resistance phenotype.
The microbiomes containing the highest proportion of ef-
flux resistance mechanisms were soils, the Giant African snail
and the phyllosphere/rhizosphere (Table 1). There was agree-
ment between the diversity and abundance data in almost all
projects. However, in a small number of projects the data did not
correlate. In the polluted soil project (MG RAST ID 3266) and the
Western English Channel (MG RAST ID 109), the contribution of
efflux to the resistance profile in terms of gene abundance were
10.5% and 0.7%, respectively, whereas in terms of diversity of re-
sistance genes it was 56% and 33%, respectively. This suggests
that while the varieties of efflux resistance genes were high, the
abundance of the efflux genes was low. The converse was also
identified e.g. in the canine intestinal microbiome (MG RAST ID
103) and one human gutmicrobiome project (MG RAST ID 98) ef-
flux constituted 24% and 23% of the variety of resistance genes
in these projects, but 43% and 39% of the total resistance gene
abundances, respectively.
This study investigated if the diversity and abundance of
potential AR genes, which confer a risk to clinical pathogen
treatment, vary across metagenomes from a wide variety of
biomes. The first section investigated the relative abundance of
non-efflux resistance genes and the second the variety of non-
efflux resistance genes. In order to minimize the potential bias
posed by the variations in the total gene content of the different
metagenomic projects, we analysed allmetagenome projects for
the relative abundance of resistance genes. The projects with
greater than one million genes were chosen (Fig. 1, Table 2), and
these comprised projects from a wide variety of biomes. The
relative abundances of resistance genes in the human projects
were the least variable, which could be due to the fact that the
human gut microbiome contains the least variability in terms of
bacterial species present. Those of the human and mammalian
projects were also the highest when taken together to represent
the biomes. There were large variations in the relative abun-
dances of the resistance genes present in the marine water and
soil projects. The highest peaks in relative abundance in thema-
rine water (MG RAST ID 109) and the WWTP PCE-dechlorinating
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Table 1. The contribution of efflux resistance genes to the total resistance diversity and abundances.
MG-RAST
Project ID Metagenome project
Total number
of different
AR genes
Number of
different
non-efflux AR
genes
Number of
different
efflux AR
genes
Efflux gene
diversity as %
of total
resistance
gene
diversity
Abundance of
efflux genes
as % of total
resistance
genes
5324 Achatina (Giant African) snail 27 7 20 74 74
611 Project for: 5mgHCH soil 21 6 15 71 76
729 Project for: 70mgHCH soil 23 7 16 70 79
2766 Phyllosphere/rhizosphere 22 8 14 64 77
3266 GenoRem GH MT (polluted soil) 18 8 10 56 10.5
2850 EarlhamMetagenomes2012 (farm soil) 18 9 9 50 70
3997 Sao Paulo Zoo Composting 45 23 22 49 33
4778 Healthy human gut microbial metagenomic
study
35 19 16 46 43
6298 Weddell’s Saddleback Tamarin Fecal
Metagenome
20 11 9 45 51
2321 Comparative metagenomics of two microbial
mats at Cuatro Cienegas basin
7 4 3 43 44
5130 Wild mice enterotypes 43 25 18 42 44
10 Twin Gut Microflora Study 49 29 20 41 29
29 Human Faeces - Kurokawa 40 24 16 40 31
109 Western English Channel Time Series 12 8 4 33 0.7
115 muegge mammals paper mammal samples MG 62 42 20 32 48
154 Gut microbiota in the Irish Elderly and its links
to health and diet
61 41 19 31 44
2558 Functional metagenomic profiling of intestinal
microbiome in extreme ageing
49 35 14 29 29
730 Project for: 124HCHsoil 7 5 2 29 67
27 Global Ocean Sampling Expedition 19 14 5 26 16
582 Project for:
DPI rumen 454 bovine and ovine combined
8 6 2 25 14
103 Canine Intestinal Microbiome 17 13 4 24 43
98 Human gut microbiome viewed across age and
geography (WGS)
101 78 23 23 39
128 The oral metagenome in health and disease 19 15 4 21 19
60 Human Gut Microbial Metagenome 60 49 11 18 16
2982 SEPRL/PoultryGut2012 6 5 1 17 1.3
5687 Circadian mouse cecum 13 11 2 15 42
731 WWTP-activated sludge plasmid (and viral)
metagenomes from Switzerland
19 17 2 11 15
1167 BIOS Microbial Oceanography Course 3 2 1 33 33
2706 Puget Sound 4 2 2 50 33
4970 Asian long horned beetle larval midgut
metagenome
4 2 2 50 40
5736 Deep biosphere 3 3 0 0 0
20 Antarctica Aquatic Microbial Metagenome 3 3 0 0 0
3744 Freshwater Lagoon Albufera 1 1 0 0 0
1449 TNPRC Rhesus monkey 1 1 0 0 0
1452 NEPRC Macaque 64 weeks 3 3 0 0 0
2374 GED Great Prairie Iowa Assembly 2 2 0 0 0
405 Rothamsted grassland soil 3 3 0 0 0
922 Metagenomics data WWTP 6 6 0 0 0
Only metagenome projects with greater than 500 000 genes were included in this table.
mixed culture (MG RAST ID 602) projects were due to the pres-
ence of the blaTEM gene. However, the relative abundances of
other projects were not as highly influenced by the blaTEM re-
sistance gene e.g. the human projects. The results of the rela-
tive diversity study concur with the variety of resistance genes
study. The greatest variety and abundanceswere detected in hu-
man gutmetagenomes. However, when analysingmetagenomic
data it is important to consider the limitations of sequencing in
relation to the depth currently possible and the actual depth re-
quired to identify low diversity genes in the dataset.
Non-efflux-mediated resistance genes to all known classes
of antibiotics were detected in at least one metagenome (Fig. 2
and Fig. S1, Supporting Information). The human gut mi-
crobiomes contained the widest variety of AR genes (n =
29–78, Table 2; Fig. S1, Supporting Information). The human oral
metagenomes, however, contained atmost 15 different AR genes
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Figure 1. Relative abundance and variety of AR genes in metagenome projects. The bar chart represents the number of different genes identified per project. The line
graph represents the relative abundance of resistance genes in each project. Each project had over 1 million gene reads.
(MG RAST ID 128). Of the wastewater treatment plants (WWTP)
metagenomes, the hospitalWWTP (MG RAST ID 1963) contained
the highest diversity (n = 24) even though the coverage was rel-
atively low at 177 214 total genes detected. However, the relative
abundance of the resistance genes was very low at 0.025%. This
project comprised both influent and WWTP sludge. In compari-
son, the non-hospitalWWTP sludge samples contained between
9, 17 and 6 different AR genes in the three projects MG RAST IDs
43, 731 and 922. The numbers of genes in the datasets were 224
738, 560 998 and 54 080 251 genes, respectively. However, the rel-
ative abundances of the resistance geneswere 0.01%, 0.047% and
2.2 × 10−5%, respectively. Thus, while the relative abundance
of resistance genes was influenced by the coverage, the relative
diversities of resistance genes were not. Metagenomic datasets
lacking AR genes were dominated by water, soil, plant or ani-
mal associated microbiomes. However, as we do not know the
limit of detection of metagenomic analysis these results may
be a function of the limits of metagenomic techniques rather
than an indication that these environments do not contain AR
genes of clinical relevance. Environmental microbiomes contain
a great diversity of bacteria, most of which are uncharacterized.
The results from metagenomic data may be influenced by bac-
terial diversity, their genome sizes and the relative abundance
of AR genes to their host DNA or the AR gene hosts to the to-
tal DNA in the sample. Therefore, while PCR will amplify a gene
present even in low relative abundance, metagenomic datasets
will only identify genes at a certain abundance within the total
DNA present.
Beta-lactamase genes were detected in the widest variety
of microbiomes of which blaTEM was most frequently identified
(Fig. S1, Supporting Information). The blaTEM genes were present
in 48 projects, including at least one metagenome project from
all of the different biomes, except the insect metagenomes (MG
RAST IDs 5324, 4970, 36), which did not contain the blaTEM genes.
The relative abundances of the blaTEM resistance genes were
the highest for any gene detected. Their abundance dominated
certain environmental metagenomes, but the blaTEM resistance
genes were not detected in an abundance of greater than 3% in
mammalian or human gut metagenomes (Table 2). The cow vi-
rome (MG RAST ID 705) and phage (MG RAST ID 484) projects
contained beta-lactam resistance genes. The blaTEM and blaCTX-M
genes were previously identified in the bacteriophage DNA iso-
lated from the human faecal microbiome (Quiro´s et al. 2014). At
a stringency of 90%, blaCTX-M was identified in one human gut
metagenome (MG RAST ID 154) and blaIMP in the hospital WWTP
(MG RAST ID 1963) (Fig. S1, Supporting Information).
There was a relatively low variety or absence of tetracycline
resistance genes in the non-animal-associated metagenomes.
The tetracycline resistance genes (tetW, tetQ, tetO) were iden-
tified exclusively in animal and human metagenomes. How-
ever, tetracycline resistance genes have been identified in high
abundance using qPCR in sewage sludge and environmental
microbiomes (Duffy, Holliger and Walsh 2014; Xu et al. 2015).
Trimethoprim is a synthetic antibiotic and not produced in na-
ture. Trimethoprim resistance genes were identified in four hu-
man metagenome projects (MG RAST IDs 98, 60, 154, 2558), one
mammalian gut metagenome project (MG RAST ID 116) and one
farm soil metagenome project (MG RAST ID 2850). The human
gut microbiomes contained the greatest diversity of trimetho-
prim resistance genes (n = 6). However, the abundance of the
trimethoprim resistance geneswas very low (less than four gene
copies) when detected.
Aminoglycoside resistance genes were detected in at least
one metagenome project from each of the different biomes.
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Table 2. Metagenomic projects ranked according to the diversity and abundance of non-efflux resistance genes.
#Genes in project ID Projects
#AB resistance
genes without efflux
Total non-efflux resistance
gene abundance as a
function of total genes (%)
Contribution of blaTEM
gene abundance to total
AR gene abundance (%)
16754433 98 Human gut 78 0.016347912 1.9
3179289 154 Human gut 42 0.013084687 1.2
2033449 116 Mammalian gut 42 0.014802437 3.0
3064560 60 Human gut 41 0.002023129 1.6
2626836 2558 Human gut 35 0.008375095 0.5
6717876 10 Human gut 29 0.021822374 0
6243927 5130 Mammalian gut 25 0.003843735 0
4879354 3997 Mammalian gut 23 0.003299617 0
1913381 128 Human oral 15 0.012700032 1.2
10729528 27 Marine 14 0.001342091 71.3
15125044 5687 Mammalian gut 11 0.002485943 0
2846938 6298 Mammalian gut 11 0.000983513 0
111255128 2850 Farm soil 9 1.16849E-05 0
4894785 109 Marine 8 0.049052206 85.3
5943390 2766 Phyllosphere/rhizosphere 8 0.000168254 10
287594033 3266 Polluted soil 8 7.40627E-05 96.4
1102372 729 Polluted soil 7 0.004444961 0
2886157 5324 Snail 7 0.00225213 0
1613523 611 Polluted soil 6 0.001549405 0
54080251 922 WWTP 6 2.21892E-05 0
1232946 2982 Poultry gut 6 0.006245205 68
12933299 405 Soil 3 0.000131444 90.2
2050142 602 WWTP 3 0.313002709 96.3
1312454 2706 Marine 2 0.000304773 0
11970451 1167 Marine 2 1.67078E-05 0
5652927 2374 Soil 2 5.30699E-05 0
1137603 4970 Larva 2 0.000263712 0
1099557 20 Marine 1 9.09457E-05 100
1131372 1449 Mammalian gut 1 0.000176777 0
With the exception of aph3iiia, all of the frequently identified
aminoglycoside resistance genes confer resistance to strepto-
mycin. Similar to the trends concerning the diversities of beta-
lactam, tetracycline and aminoglycoside resistance genes, the
greatest diversity of chloramphenicol resistance genes was also
identified within the human gut microbiomes (MG RAST IDs 98,
60, 154, 2558, 10). Overall, the catA gene was the most frequently
identified chloramphenicol resistance gene. Eleven different,
non-efflux-mediated, macrolide resistance genes were identi-
fied, which were present in human gut (n = 11), mammalian
gut (n = 6), WWTP (n = 3) or soil microbiomes (n = 3) (Fig. S1,
Supporting Information). The sul1 and sul2 genes were identi-
fied in human (n= 6) andmammal (n= 4)metagenomes,WWTP,
soil and marine and freshwater metagenomes, but the sul3 was
restricted to one mammalian metagenome project, which also
contained the sul1 and sul2 genes (MG RAST ID 116). The van-
comycin resistance genes were identified in few metagenome
projects, which were confined to human gut (MG RAST IDs 98,
60, 154, 10) and mammalian (MG RAST IDs 116, 5130, 5687, 6244,
1452) microbiomes. The two plasmid-mediated quinolone re-
sistance genes, qnrB and qnrS, were detected in four and one
metagenomedatasets, respectively (Fig. S1, Supporting Informa-
tion). The qnrB gene was identified in human gut microbiomes
(MG RAST ID 98, 2558), a marine microbiome (MG RAST ID 27)
and the giant African snail microbiome (MG RAST ID 5324). The
qnrS gene was identified in a WWTP associated with a hospi-
tal (MG RAST ID 1963). The qnrB and qnrS resistance genes have
been previously identified in human samples (Folster et al. 2011),
WWTPs (Su et al. 2014a) and aquatic environments (Zhang et al.
2012). As snailmicrobiomes have not been analysed for the pres-
ence of AR genes, these genes have not previously been identi-
fied in a snail microbiome.
DISCUSSION
The results discussed in this study were all derived from
metagenomic studies. While metagenomes provide a wealth of
data in comparison to culture-based or PCR-based studies from
total community DNA, they have limitations. In complex micro-
biomes such as soil, the metagenomics technique is prone to
the limitations and bias of all molecular techniques e.g. nucleic
acid extraction, or specific limitations and bias such as the depth
of coverage required to represent the minor or rare members
of the community and genes. Therefore, complete coverage is
normally not obtained. The deep coverage of the majority of a
soil community is not achieved, even with 300 Gbp of sequence
data (Howe et al. 2014). Thus, rare members of the soil or other
complex microbiomes, which contain AR genes, may have been
missed.With further advancements in sequencing technologies,
we will hopefully soon reach the depth required to analyse both
the rare and major bacteria species in complex microbiomes.
Studies have identified the presence of AR genes in a wide
variety of ecological niches (Feller, Sonnet and Gerday 1995; de
Kraker and van de Sande-Bruinsma 2007; Allen et al. 2009; Can-
tas et al. 2013; Walsh and Duffy 2013; Duffy, Holliger and Walsh
2014; Garcia-Migura et al. 2014). However, the presence of a
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Figure 2. Total AR gene distributions throughout the entire metagenome project
database. Blue = presence of non-efflux AR gene conferring resistance to this
class. Red = absence of non-efflux AR gene conferring resistance to this class.
resistance gene does not indicate if this is the source or sink of
the resistance gene. Thus, while metagenomic data may be uti-
lized to identify the presence of resistance, they have not to date
been used to answer questions relating to ecological connectiv-
ity of resistance genes. Studies have identified that AR genes
may have an environmental reservoir. Soil is thought to be a
substantial source of AR genes, and it is thought that antibiotic-
producing microorganisms in soil are the source of resistance
genes found in clinical pathogens (Canton 2009). However, direct
evidence of gene transfer between the environmental resistome
and the clinic is rare as resistance genes may undergo many
rounds of evolution between the soil and the clinic (Aminov
and Mackie 2007). Fresh vegetables may provide the potential
link between the environment and clinic through the inges-
tion of antibiotic-resistant bacteria. However, research to date
has focused on antibiotic-resistant pathogenic bacteria, such
as Salmonella sp. and Enterobacteriaceae, which do not provide
information about the extent to which commensal and non-
pathogenic bacteria act as AR reservoirs (van Hoek et al 2015).
Our results suggest that soil, plant, insect and marine mi-
crobiomes use the non-specific efflux-mediated mechanisms to
protect themselves from antibiotics. This finding has been iden-
tified in a study of metagenomic data from soil and culturable
antibiotic-resistant bacteria from soil (Walsh and Duffy 2013;
Nesme et al. 2014). Among the projects with the highest diver-
sity of efflux resistance mechanisms were two contaminated
soils (MG RAST IDs 611, 729), which concur with the hypothesis
that these resistancemechanisms were not necessarily selected
due to antibiotic selection, but rather toxins, which the bacteria
pump out of the cell. Efflux resistance mechanisms are not an-
tibiotic specific, but generically pump out toxins. Our study fo-
cused predominantly on the non-efflux resistance genes tomin-
imize the bias due to such non-antibiotic influences.
We have demonstrated that soil and the environment con-
tain potential AR genes of clinical importance and may be
sources of the basic forms of AR genes e.g. blaTEM. However,
the human and mammalian gut microbiomes contained the
greatest diversity and relative abundance of AR genes. This has
been borne out in the high diversity of resistance genes to al-
most all classes of antibiotics identified in these microbiomes in
comparison to human oral or non-mammalian microbiomes.
Trimethoprim is a synthetic antibiotic and therefore not pro-
duced in nature. The trimethoprim resistance genes were
identified in human and mammalian gut microbiomes and in
one farm soil microbiome. The presence in the absence of di-
rect selective pressure may be due to their frequent localization
on integrons and coselection due to other genes present on the
same mobile element.
The data presented in this study must be viewed in con-
text. The vast majority of research into AR has focused on re-
sistance present in human pathogenic bacteria. Therefore, the
databases of genes are biased towards those associated with
human pathogens. However, our aims were restricted to clini-
cally important resistance genes. Thus, the bias afforded by the
high proportion of clinically relevant resistance genes in the
databases aids to answer our questions regarding the biomes
containing the greatest diversity and levels of clinically impor-
tant resistance genes.
Martı´nez, Coque and Baquero (2015) suggested that a series
of bottlenecks occur in the transfer of AR genes between soil,
water, animals, sewerage and humans.
The first bottleneck is ecological connectivity: a gene trans-
fer event only occurs when donor and recipient populations
come into contact. The second bottleneck is based on the
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founder effect: when one resistance determinant is broadly dis-
tributed among bacterial populations, it is rare that another
resistance determinant that has the same or a closely related
substrate profile is acquired; bacteria are already resistant and,
consequently, antibiotics do not exert any selective pressure
on an organism that already harbours a gene with the same
function.
The third bottleneck that determines the spread of a given
resistance gene is fitness cost.
We applied these bottleneck theories to our data using one
highly abundant resistance gene, which is widespread through-
out different metagenomes, blaTEM and another, which is not
e.g. blaCTX-M. These theories as applied to blaTEM suggest that all
metagenomes containing this gene are connected and are ca-
pable of transferring this gene between them, as it is present in
almost all metagenomes. As this gene was also in relatively high
abundance across many metagenome projects, the second bot-
tleneck suggests that another resistance gene with similar sub-
strate would be rare. This is the case in metagenome projects
containing a low diversity of resistance genes. However, sev-
eral different beta-lactamases were identified in many human
andmammalian gut andWWTPmetagenomes. Thus, the blaTEM
gene can exist in the presence of similar resistance genes, which
suggests that either this theory is incorrect. The third bottle-
neck, which the blaTEM gene has overcome, is the fitness costs
associated with this gene. In order to have successfully trans-
ferred to such a large number of microbiomes, it must not bear
a fitness burden.
We have defined the resistance genes in this study as
those with high similarity to resistance genes present in
clinical pathogens as we wished to identify if specific mi-
crobiomes posed a greater risk to human health than oth-
ers. Recent debates have developed on how to prioritize
risks associated with the presence of resistance genes in
metagenomic datasets (Bengtsson-Palme and Larsson 2015;
Martı´nez, Coque and Baquero 2015). The question emerging
from this debate is whether to assign the greatest risk to
AR genes already present in human pathogens or to those
which are as yet unknown, but could potentially transfer to
human pathogens. Bengtsson-Palme and Larsson argue that
the transfer of known resistance genes is probably rare and
therefore, as they are already present in human pathogens
are unlikely to dramatically alter patient outcomes. Whereas
Martı´nez, Coque and Baquero (2015) suggests that the high-
est risk to patients is from mobile resistance genes for which
a role in resistance in human pathogens has already been
demonstrated.
Using the data generated in this study, we have identified
a wide range of AR genes, which are associated with mobile
elements and have been shown to generate resistance pheno-
types in human pathogens. Our results suggest that not all re-
sistance genes can be grouped together to determine their risk,
but should be analysed individually and in terms of their mi-
crobiome or bacterial context. The bottlenecks described ear-
lier prevent certain resistance genes ever coming in contact
with pathogens. If the resistance genes are capable of overcom-
ing these bottlenecks then they will be ubiquitous, regardless
of their function as shown by blaTEM. However, if the bottle-
necks prevent the gene from transferring to or beingmaintained
within a pathogen, then its presence in high or low abundance
outside the pathogen poses no risk to the human health. The
risk arises when the resistance gene e.g. blaCTX-M is present and
when transferred to a human pathogen can then be maintained
within the pathogen and spread between different pathogens.
In order for these rare genes to pose a risk to human health,
they must be provided with the opportunity for proliferation,
most frequently by the use of antibiotics. The AR mechanisms,
which pose the greatest risk to human health, are those that
are capable of transferring to other bacteria, especially human
pathogens (Martı´nez, Coque and Baquero 2015).
When using metagenomics data to identify risk the context
of the results and the limitations of the technique must be em-
phasized. Our findings indicated that the human and mam-
malian metagenomic datasets contained the greatest diversity
and relative abundance of clinically relevant AR genes. However,
we do not know the minimum coverage required in order to de-
tect the rare AR genes or AR genes, which are present in a very
diversemetagenome. Therefore, in order to identify AR gene risk
using metagenomic data we must first identify the limits of de-
tection of this technique, and second identify how we can nor-
malize datasets containing vastly different diversities of micro-
bial species and genome sizes. If we do not detect the AR gene
is it in fact not there or just below the limits of our techniques?
Once we have identified these caveats, we then need to under-
stand if the context of the AR gene, is it on a promiscuous plas-
mid, capable of transferring to many species or is it present on
the chromosome? Finally, we need to understand whether one
copy of a gene in a totalmetagenomic dataset of over onemillion
genes poses a risk to the treatment of a patient.
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